期刊文献+

宫颈小细胞癌组织中血管内皮生长因子的表达及临床意义 被引量:1

Expression of vascular endothelial growth factor in small cell carcinoma of uterus cervix and its clinical significance
下载PDF
导出
摘要 目的:检测血管内皮生长因子(VEGF)在宫颈小细胞癌(SCCC)中的表达及其与SCCC病理和临床的关系,为预测SCCC转移、评价预后及合理治疗提供科学依据。方法:采用免疫组化EnV ision二步法检测VEGF在SCCC中的表达。结果:4例SCCC组织中VEGF均为阳性。结论:VEGF与SCCC的发生、发展密切相关,SCCC早期即有淋巴结转移、脉管浸润以及病情进展迅速均与VEGF的高表达有关。VEGF可作为评估SCCC的淋巴结转移状况、选择治疗方案及判断预后的指标。 Objective: To study the expression of vascular endothelial growth factor(VEGF) in small cell carcinoma of cervis ( SCCC ) and its relationship with the clinical and pathological features, so as to predict the metastasis of SCCC, to evaluate the prognosis and to manage a proper treatment. Methods : EnVision two step immunohistochemical method was used to observe the expession of VEGF in the samples of small cell carcinoma of cervis. Results : Four samples were obtained from surgical specimens of the patients with SCCC in our hospital. In all the samples, the expression of VEGF was positive. Conclusion: VEGF is closely related with the oncogenesis and development of SCCC. In the earlier period of SCCC, the lymph node involvement and vascular invasion are common. The aggressive progression of SCCC must have something to do with the highly expression of VEGF. The expression of VEGF can be used as an index in selecting treatment and predicting prognosis of SCCC.
出处 《医学研究生学报》 CAS 2005年第11期986-988,i0007,共4页 Journal of Medical Postgraduates
关键词 宫颈小细胞癌 血管内皮生长因子 免疫组化 Small cell carcinoma of cervis Vascular endothelial growth factor Immunohistochemistry
  • 相关文献

参考文献10

  • 1Stephen SS.回允中主译.诊断外科病理学[M].第三版.北京:北京大学医学出版社,2003.2174-2177.
  • 2McMahon G. VEGF receptor signaling in tumor angiogenesis [J].Oncologist,2000,5 (Suppl): 310.
  • 3李凌,徐萍,胡宏慧,刘文文,易苗英,李川源,黄倩.一种新的肿瘤血管生成模型[J].生物化学与生物物理学报,2002,34(1):21-27. 被引量:9
  • 4Shi W, Siemann DW. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor [J]. Br J Cancer, 2002,87 (1):119-126.
  • 5Fujiwaki R, Hate K, Iida K, et al. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogensis, tumor cell proliferation,and apoptosis [J]. Anticancer Res, 2000,20 (2B):1317-1322
  • 6Dobbs SP, Hewett PW, Johnson IR,et al. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia [J]. Br J Cancer, 1997, 76 (11):1410-1415.
  • 7邹三鹏,张薛榜,麻东辉,张王刚.VEGF-C在浸润性宫颈癌中的表达及意义[J].陕西医学杂志,2004,33(2):105-108. 被引量:9
  • 8Cheng WF, Chen CA, Lee CA, et al. Vascular endothelial growth factor in cervical carcinoma [J]. Obstet Gynecol, 1999, 93(5Pt1) :761-765.
  • 9Sevin BU, Method MW, Nadji M,et al. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix [J]. Cancer, 1996, 77 (8):1489-1493.
  • 10van Nagell JR J, Donaldson ES, Wood EG,et al. Small cell cancer of the uterine cervix [J]. Cancer, 1977,40 (5): 2243-2249.

二级参考文献12

  • 1Wu WS Yin KZ 等.-[J].中国肿瘤临床,1996,23:751-756.
  • 2[1]Lee J, Gray A, Yuan J, et al. Vascular endothelial growth factor related protein: a ligand and specific activator of the tyrosine kinase receptor. Proc Natl Acad Sci USA, 1996;93 : 1988
  • 3[2]Paavonen K, Hoteiij KN, Chilov D, et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation, 1996; 93 (6) :1079
  • 4[3]Chilov D,Kukk E,Taira S, et al. Genomil organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem, 1997;272(40) : 25176
  • 5[4]Kukk E, Lymboussaki A, Taira S, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 1996;122(12): 3829
  • 6[5]Witzenbichler B, Asahara T, Murohara T, et al.Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. AMJ Pathol, 1998 ; 153 (2): 381
  • 7[6]Sain S ,Maria B,Jose A,et al, VEGFc and VEGFR-3 expression in human thyroid pathologies .Int J Cancer, 2000;86(1) : 47
  • 8[7]Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer, 2002 ; 38 (10):1413
  • 9[8]Noguchi T, Takeno S, Shibata T, et al. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep, 2002;9(5) : 995
  • 10[9]He Y, Kozaki K, Karpanen T. Suppression of tumor lymph- angiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst, 2002;94(11): 785

共引文献17

同被引文献23

  • 1姜汉国,高嵋,唐慰萍,李飞虹,蔡琼珍.VEGF、VEGF-C和VEGF-D在甲状腺乳头状癌组织中的表达及意义[J].癌症,2005,24(9):1136-1139. 被引量:11
  • 2Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis [J]. Physiol Rev, 2002,82(3) : 673-700.
  • 3Joukov V, Pajusola K, Kaipainen A, et al . A novel endothelial growth factor, VEGF-C, is a ligand for the Flt4( VEGFR-3 ) and KDR(VEGFR-2) receptor tyrosine kinases[ J ]. EMBO J, 1996, 15(2) :290-298.
  • 4Achen MG,Jeltsch M ,Kukk E,et al. Vascular endothelial growth factor-D(VEGF-D) is a ligand for the tyrosine kinases VEGF receptor-2( Flkl ) and VEGF receptor-3 ( Flt4 ) [J]. Proc Natl Acad Sci USA, 1998, 95(2) :548-553.
  • 5Fujimoto J, Sakaguchi H, Hirose R, et al. Progestins suppress estrogen-induced expression of VEGF subtypes in uterine endometrial cancer cells [ J ]. Cancer Lett, 1999, 141 (1-2) :63-71.
  • 6Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation [ J ]. Nature, 2000, 407 ( 6801 ) :242 -248.
  • 7Makinen T, Veikkola T, Mustjoki S, et al. Isolated lymphatic endothelial cells transduce growth , survival and migratory signals via the VEGF-C/D receptor VEGFR-3 [J]. EMBO J, 2001,20 ( 17 ) :4762-4773.
  • 8Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases [J]. Nature, 2000, 407(6801):249-257.
  • 9Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues [J]. FASEB J,2000,14 ( 13 ) :2087 -2096.
  • 10Wigle JT, Oliver G. Proxl function is required for the development of the murine lymphatic system [J]. Cell, 1999, 98 (6) : 769 -778.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部